• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

杂合肽DNA纳米材料可实现高效广谱的病毒中和作用。

Hybrid peptide DNA nanomaterials enable potent and broad-spectrum virus neutralization.

作者信息

Umrao Saurabh, Dwivedy Abhisek, Haak Payton L, Gandavadi Dhanush, Rund Laurie A, Chen Chi, Zhou Lifeng, Duan Jinwei, Fang Ying, Steelman Andrew J, Wang Xing

机构信息

Department of Bioengineering, Grainger College of Engineering, University of Illinois at Urbana-Champaign, Urbana, IL, USA.

Nick Holonyak Jr. Micro and Nanotechnology Laboratory, Grainger College of Engineering, University of Illinois at Urbana-Champaign, Urbana, IL, USA.

出版信息

bioRxiv. 2025 Jul 25:2025.07.21.666049. doi: 10.1101/2025.07.21.666049.

DOI:10.1101/2025.07.21.666049
PMID:40777507
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12330609/
Abstract

The continued emergence of antigenic drift and drug-resistant viral strains highlights the need for antiviral strategies that deliver robust efficacy, broad subtype coverage, and minimal off-target toxicity. We demonstrate a potent and broad-spectrum strategy that employs hybrid biomaterials of Urumin (a host defense peptide) and a honeycomb (HC) DNA origami through spatially organized multivalent presentation for enhanced antiviral efficacy. Molecular dynamics simulations reveal that Urumin penetrates and destabilizes the hemagglutinin (HA) trimer core, disrupting influenza A viral (IAV) entry. Arranging Urumin in trimeric clusters on the HC enables potent multivalent binding to trimeric HAs on IAV, enhancing antiviral efficacy at nanomolar concentrations, ~1,000-fold more effective than free Urumin. In vitro assays confirm HC-Urumin outperforms free Urumin in blocking viral entry and preserving cell viability in more IAV subtypes. In vivo studies show that compared to free Urumin, HC-Urumin treatment reduces disease severity, preserves physiological behavior, and decreases mortality in infected mice, while maintaining virus-specific adaptive immune responses without altering humoral immunity. Our study offers an advanced and effective materials platform and strategy for broad-spectrum, low-dose intervention against human and animal IAVs, which can be adapted to combat other viruses by patterning corresponding host defense peptides on custom designed DNA nanostructures.

摘要

抗原性漂移和耐药性病毒株的不断出现凸显了对抗病毒策略的需求,这些策略需具备强大的疗效、广泛的亚型覆盖范围以及最小的脱靶毒性。我们展示了一种高效且广谱的策略,该策略通过空间组织的多价展示,利用乌鲁明(一种宿主防御肽)和蜂窝状(HC)DNA折纸的混合生物材料来增强抗病毒效果。分子动力学模拟表明,乌鲁明能够穿透并破坏血凝素(HA)三聚体核心,从而干扰甲型流感病毒(IAV)的进入。将乌鲁明排列在HC上的三聚体簇中,能够与IAV上的三聚体HA进行有效的多价结合,在纳摩尔浓度下增强抗病毒效果,比游离的乌鲁明有效约1000倍。体外试验证实,在阻断病毒进入以及在更多IAV亚型中保持细胞活力方面,HC - 乌鲁明优于游离的乌鲁明。体内研究表明,与游离的乌鲁明相比,HC - 乌鲁明治疗可降低疾病严重程度,保持生理行为,并降低感染小鼠的死亡率,同时维持病毒特异性适应性免疫反应而不改变体液免疫。我们的研究为针对人和动物IAV的广谱、低剂量干预提供了一个先进且有效的材料平台和策略,通过在定制设计的DNA纳米结构上构建相应的宿主防御肽,该平台和策略可适用于对抗其他病毒。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efcb/12330609/c9a50d24d31c/nihpp-2025.07.21.666049v1-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efcb/12330609/8ed3c72a619d/nihpp-2025.07.21.666049v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efcb/12330609/7e27ed032982/nihpp-2025.07.21.666049v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efcb/12330609/8da7266abd8f/nihpp-2025.07.21.666049v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efcb/12330609/e6e5d60ac87f/nihpp-2025.07.21.666049v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efcb/12330609/27631ab9c6cf/nihpp-2025.07.21.666049v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efcb/12330609/c9a50d24d31c/nihpp-2025.07.21.666049v1-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efcb/12330609/8ed3c72a619d/nihpp-2025.07.21.666049v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efcb/12330609/7e27ed032982/nihpp-2025.07.21.666049v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efcb/12330609/8da7266abd8f/nihpp-2025.07.21.666049v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efcb/12330609/e6e5d60ac87f/nihpp-2025.07.21.666049v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efcb/12330609/27631ab9c6cf/nihpp-2025.07.21.666049v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efcb/12330609/c9a50d24d31c/nihpp-2025.07.21.666049v1-f0006.jpg

相似文献

1
Hybrid peptide DNA nanomaterials enable potent and broad-spectrum virus neutralization.杂合肽DNA纳米材料可实现高效广谱的病毒中和作用。
bioRxiv. 2025 Jul 25:2025.07.21.666049. doi: 10.1101/2025.07.21.666049.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
A small molecule compound targeting hemagglutinin inhibits influenza A virus and exhibits broad-spectrum antiviral activity.一种针对血凝素的小分子化合物抑制甲型流感病毒并具有广谱抗病毒活性。
Acta Pharmacol Sin. 2024 Nov;45(11):2380-2393. doi: 10.1038/s41401-024-01331-7. Epub 2024 Jul 10.
4
Trained ILCs confer adaptive immunity-independent protection against influenza.经过训练的固有淋巴细胞可提供独立于适应性免疫的流感防护。
J Virol. 2025 Aug 4:e0053225. doi: 10.1128/jvi.00532-25.
5
IFIT3 RNA-binding activity promotes influenza A virus infection and translation efficiency.IFIT3的RNA结合活性促进甲型流感病毒感染及翻译效率。
J Virol. 2025 Jul 22;99(7):e0028625. doi: 10.1128/jvi.00286-25. Epub 2025 Jun 11.
6
Quantifying the impact of vaccination on transmission and diversity of influenza A variants in pigs.量化疫苗接种对猪甲型流感病毒变种传播和多样性的影响。
J Virol. 2024 Dec 17;98(12):e0124524. doi: 10.1128/jvi.01245-24. Epub 2024 Nov 12.
7
Heterogeneity across mammalian- and avian-origin A(H1N1) influenza viruses influences viral infectivity following incubation with host bacteria from the human respiratory tract.哺乳动物源和禽源甲型H1N1流感病毒的异质性影响了与人类呼吸道宿主细菌孵育后的病毒感染性。
Microbiol Spectr. 2025 Aug 18:e0097725. doi: 10.1128/spectrum.00977-25.
8
Antigenic Characterization and Pandemic Risk Assessment of North American H1 Influenza A Viruses Circulating in Swine.北美猪流感病毒的抗原特征和大流行风险评估。
Microbiol Spectr. 2022 Dec 21;10(6):e0178122. doi: 10.1128/spectrum.01781-22. Epub 2022 Nov 1.
9
Greater Breadth of Vaccine-Induced Immunity in Females than Males Is Mediated by Increased Antibody Diversity in Germinal Center B Cells.女性比男性诱导的疫苗免疫范围更广,这是由生发中心 B 细胞中抗体多样性增加介导的。
mBio. 2022 Aug 30;13(4):e0183922. doi: 10.1128/mbio.01839-22. Epub 2022 Jul 20.
10
Ophthalmia Neonatorum新生儿眼炎

本文引用的文献

1
Engineering Novel DNA Nanoarchitectures for Targeted Drug Delivery and Aptamer mediated Apoptosis in Cancer Therapeutics.工程化新型DNA纳米结构用于癌症治疗中的靶向药物递送和适体介导的细胞凋亡
Adv Funct Mater. 2025 May 29;35(22). doi: 10.1002/adfm.202425394. Epub 2025 Feb 7.
2
Modeling the impact of early vaccination in an influenza pandemic in the United States.模拟美国流感大流行期间早期疫苗接种的影响。
NPJ Vaccines. 2025 Mar 29;10(1):62. doi: 10.1038/s41541-025-01081-5.
3
Prophylactic clemastine treatment improves influenza A virus-induced cognitive dysfunction in mice.
预防性氯马斯汀治疗可改善甲型流感病毒诱导的小鼠认知功能障碍。
Brain Behav Immun Health. 2024 Oct 9;42:100891. doi: 10.1016/j.bbih.2024.100891. eCollection 2024 Dec.
4
A neuraminidase-based inactivated influenza virus vaccine significantly reduced virus replication and pathology following homologous challenge in swine.一种基于神经氨酸酶的灭活流感病毒疫苗在猪受到同源攻击后显著降低了病毒复制和病理变化。
Vaccine. 2025 Feb 6;46:126574. doi: 10.1016/j.vaccine.2024.126574. Epub 2024 Dec 7.
5
Bioinspired designer DNA NanoGripper for virus sensing and potential inhibition.受生物启发的设计 DNA 纳米夹用于病毒感测和潜在抑制。
Sci Robot. 2024 Nov 27;9(96):eadi2084. doi: 10.1126/scirobotics.adi2084.
6
Tackling Influenza A virus by M2 ion channel blockers: Latest progress and limitations.通过 M2 离子通道阻滞剂对抗甲型流感病毒:最新进展与局限性。
Eur J Med Chem. 2024 Mar 5;267:116172. doi: 10.1016/j.ejmech.2024.116172. Epub 2024 Feb 3.
7
Net-Shaped DNA Nanostructure-Based Lateral Flow Assays for Rapid and Sensitive SARS-CoV-2 Detection.基于网状 DNA 纳米结构的侧向流动分析用于快速灵敏检测 SARS-CoV-2。
Anal Chem. 2024 Feb 27;96(8):3291-3299. doi: 10.1021/acs.analchem.3c03698. Epub 2024 Feb 2.
8
Co-evolution of immunity and seasonal influenza viruses.免疫与季节性流感病毒的共同进化。
Nat Rev Microbiol. 2023 Dec;21(12):805-817. doi: 10.1038/s41579-023-00945-8. Epub 2023 Aug 2.
9
The influenza virus PB2 protein evades antiviral innate immunity by inhibiting JAK1/STAT signalling.流感病毒 PB2 蛋白通过抑制 JAK1/STAT 信号通路来逃避抗病毒固有免疫。
Nat Commun. 2022 Oct 21;13(1):6288. doi: 10.1038/s41467-022-33909-2.
10
Influenza.流感。
Lancet. 2022 Aug 27;400(10353):693-706. doi: 10.1016/S0140-6736(22)00982-5.